Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal...

31
introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam [email protected] ESSIC Meeting Baden 16-18 June 2005
  • date post

    19-Dec-2015
  • Category

    Documents

  • view

    216
  • download

    0

Transcript of Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal...

Page 1: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

introduction to the design of diagnostic criteria

Joop P van de MerweDept. of Immunology

& Internal MedicineErasmus MC Rotterdam

[email protected]

ESSIC Meeting Baden 16-18 June 2005

Page 2: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

2 * Fries JF et al. Arthritis Rheum 1994;37:454-62

Types and purposes of criteria*

Type Purpose

Classification criteria To separate those with a specific disease from those without the disease

Subclassification criteria To separate diseases or subsets within a disease cluster

Prognostic criteria To separate subjects with good or potentially favorable outcomes from those with bad outcomes

Status indexes To assess present disease activity or accumulated damage from the disease

Activity indexes (implies reversibility)

To estimate current disease activity status

Damage indexes (implies irreversibility)

To estimate accumulated damage from the disease

Outcome criteria To measure the overall impact of a disease and to serve as dependent variables for clinical studies

Page 3: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

3

* Fries JF et al. Arthritis Rheum 1994;37:454-62 (modified)

CLASSIFICATION CRITERIA*

Classification criteria separate patients with the disease from the general population and from patients with potentially confusable conditions

Persons with Diseases

Persons with ConfusableDiseases

All Persons

Persons with Target

Disease

Page 4: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

4

overlapping features

example: systemic autoimmune diseases

the problem

Page 5: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

5

systemic autoimmune diseases (1)

• rheumatoïd arthritis• Sjögren's syndrome• systemic lupus erythematosus (SLE)• antiphospholipid syndrome (APS)• mixed connective tissue disease (MCTD)• systemic sclerosis (scleroderma, CREST-syndrome) • polymyositis / dermatomyositis• relapsing polychondritis

examples

Page 6: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

6

possible features

clinical

• arthritis / arthralgia• vasculitis• fever• Raynaud's phenomenon• fatigue• various renal diseases

laboratory

• increased ESR, CRP• anaemia • leukopenia• rheumatoid factor• ANA• trombopenia

systemic autoimmune diseases (2)

not specific

for

one single disease

not specific

for

one single disease

Page 7: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

7

possible accompaning organspecific autoimmune diseases

• atrophic gastritis - pernicious anaemia• Hashimoto's disease• keratoconjunctivitis sicca • lymfocytic interstitial pneumonitis • myositis • pericarditis, pleuritis • peripheral neuropathy • uveitis (iritis, iridocyclitis)• scleritis • interstitial cystitis

systemic autoimmune diseases (3)

no combination is specific

for one single disease

Page 8: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

8

how do you recognize them ?

systemic autoimmune diseases (4)

Page 9: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

9

people

how do you recognize them ?

each person

has a face

Page 10: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

10

people

how do you recognize them ?

none of the

parts of the

face is unique,

but the

combination is

Page 11: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

11

people

how do you recognize them ?

none of the

parts of the

code is unique,

but the

combination is

Page 12: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

12

each autoimmune disease

has its own "face"

how do you recognize them ?

systemic autoimmune diseases (4)

Page 13: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

13

systemic autoimmune diseases (5)

characteristic feature

specific way it affects the lacrimal and salivary glandsspecific way it affects the joints specific way it affects the skin specific way it affects the skin

combination of clinical symptoms and anti-RNP specific way it affects the skin combination of symptoms

disease

Sjögren's syndrome

rheumatoid arthritissystemic lupus erythematosus subacute cutaneous lupus erythematosus mixed connective tissue disease (MCTD)systemic sclerosis (scleroderma) CREST syndrome

characteristic features

Page 14: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

14

characteristic features

what are the characteristic features of IC ?

• what is the consequence of the PBS/IC concept ?

ICS definition of PBS/IC

PBS: "suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency in the absence of infection or other pathology"

IC: above with "typical cystoscopic and histological features"

Page 15: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

15

characteristic features

what are the "typical cystoscopic and histological features of IC" ?

what has happened to urgency ?

ICS definition of IC may be written as:

suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency with typical cystoscopic and histological features in the absence of infection or other pathology

what are the characteristic features of IC ?

Page 16: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

16

characteristic features

what are the "typical cystoscopic and histological features of IC" ?

Cysto features: Hunner's ulcer or low capacity

epithelial denudation, submucosal inflammation, granulation tissue, edema, congestion, haemorrhage; detrusor fibrosis (and myopathy)

increased mast cell number & activation and neuronal staining

from: Hanno P, Burks D. Painful bladder syndrome / interstitialcystitis. Course 93 IC, AUA 2005 Annual Meeting, San Antonio, TX, May 21-26,2005

Page 17: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

17

characteristic features

Cysto features: Hunner's ulcer or low capacity

epithelial denudation, submucosal inflammation, granulation tissue, edema, congestion, haemorrhage; detrusor fibrosis (and myopathy)

increased mast cell number & activation and neuronal staining

from: Hanno P, Burks D. Painful bladder syndrome / interstitialcystitis. Course 93 IC, AUA 2005 Annual Meeting, San Antonio, TX, May 21-26,2005

does this matter as long as the combination is unique ?

but these are not unique for IC !

Page 18: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

18

PBS / IC concept

PBS

IC

PBS

orIC

IC has "typical" cystoscopic and histological features of IC in addition tosuprapubic pain and frequency

Page 19: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

19

gold standard

gold standard = diagnosis by experts

why ?- the diagnosis by experts is the best standard we have as long as the cause of a disease is unknown

advantage- non-experts can diagnose a disease as if they were experts (skill level)- diagnoses are made on the same basis by experts and non-experts (uniformity)- rules are based on information from many experts (acceptance and support)

Page 20: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

20 Arthritis Rheum 1990;33:1137-44

classification methods (1)

classification tree

the classification tree is constructed by repeated splits of groups into 2 descendant subgroups

Page 21: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

21 Arthritis Rheum 1990;33:1137-44

classification tree

pro

• items may be polychotomous or continuous

• nonparametric: no reference to a model for the

relationship between classification items and disease

status

• high information content - classified groups of subjects in

studies may be referred to the exact classifying subgroup

of the tree

Page 22: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

22

"number of criteria present rule"

Ann Rheum Dis 2002;61:554-8

Page 23: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

23 Arthritis Rheum 1990;33:1137-44

classification methods (2)

con• simple definitions (+/-): - all items are given equal weight - all items must be dichotomous (+/-)

little insight into the characteristics of a classified patient group

pro• simple definitions (+/-): easy application

"number of items present rule"

Page 24: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

24

1. collect what information (symptoms and signs*) is used

by experts to diagnose IC and

differentiate IC from confusable diseases

for both men and women

suggested approach in a multicentre study

* requires definitions and decisions on data format

Page 25: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

25

2. collection of data from

patients with IC and

patients with confusable diseases

to define classification criteria for IC

(training phase)

sensitivity specificity

suggested approach in a multicentre study

calculate an optimal combinationon the basis of how many false negative and false positivediagnoses we accept

Page 26: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

26

3. validation with new patient groups

suggested approach in a multicentre study

the same database can be used to create

number of items present rule

for clinical diagnoses and a

classification tree

for scientific studies

Page 27: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

27

data may be

- continuous

avoid entry of cut-off points for continuous data

but have the statistical analysis decide

- categorical

data format

Page 28: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

28

tests to be evaluated for their diagnostic value

should be done in all patients with IC and confusable

diseases

1. antiproliferative factor

2. ................................

3. ................................

to be evaluated ….

Page 29: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

29

1. decision on broad definition of IC

PBS + "typical" cystoscopy and/or histology

2. select diseases with which IC can be confused

(confusable diseases, CD)

list to be discussed this morning

3. what information is needed to distinguish IC from CD:

follows from (2) but needs discussion and decision

4. decision on what percentage of false negative and

false positive diagnoses we accept

summary & conclusions (1)

Page 30: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

30

5. decision on gold standard for the diagnosis IC

diagnosis by experts

6. decision on methods of classification

classification tree and

"number of items present rule"

7. decision to perform a small pilot to test procedures

8. decision on tests to be evaluated

APF test

summary & conclusions (2)

Page 31: Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal Medicine Erasmus MC Rotterdam j.vandemerwe@erasmusmc.nl.

31

consensus on IC